Executive Management Team
Chief Executive Officer
Kurt Lemvigh joined Lombard Medical in April 2017 as Chief Executive Officer. He is a veteran medical device executive with more than 30 years of experience creating profitable growth. He currently resides in the U.K. and has held senior sales, marketing and operational positions at various public and private companies including Spacelabs, Cardiac Science, GE and Marquette-Hellige. In addition to Europe and the United States, Lemvigh has conducted business in numerous international markets around the world including the Middle East, Japan, China, India and Latin America.
Chief Technology Officer
Peter Phillips has a PhD from Guy’s Hospital London. Dr. Phillips co-developed the Aorfix stent-graft and led the development and commercialization of Aorfix from 1995. He is the Company’s leading expert on the technology and its clinical application. In 2006, Dr. Phillips moved to the United States to become President of Lombard’s U.S. subsidiary, which was set up to support the Aorfix U.S. clinical trial. Upon returning to the United Kingdom in 2009, he took up the position of Chief Technology Officer. Dr. Phillips was a director of Surgicraft Ltd, a UK orthopedics company.